These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

456 related items for PubMed ID: 15822104

  • 1. Other pharmacological treatments for motor complications and dyskinesias.
    Waters C.
    Mov Disord; 2005; 20 Suppl 11():S38-44. PubMed ID: 15822104
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Treatment of levodopa-induced motor complications.
    Stocchi F, Tagliati M, Olanow CW.
    Mov Disord; 2008; 23 Suppl 3():S599-612. PubMed ID: 18781681
    [Abstract] [Full Text] [Related]

  • 4. Optimizing pharmacotherapy: strategies to manage the wearing-off phenomenon.
    Tse W.
    J Am Med Dir Assoc; 2006 Sep; 7(7 Suppl 2):12-7. PubMed ID: 17948614
    [Abstract] [Full Text] [Related]

  • 5. Mid-stage parkinsonism with mild motor fluctuations.
    Tolosa E, Valldeoriola F.
    Clin Neuropharmacol; 1994 Sep; 17 Suppl 2():S19-31. PubMed ID: 9358192
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Parkinson's disease: drug therapy.
    Oertel WH, Quinn NP.
    Baillieres Clin Neurol; 1997 Apr; 6(1):89-108. PubMed ID: 9426870
    [Abstract] [Full Text] [Related]

  • 8. New and emerging strategies for improving levodopa treatment.
    Tolosa ES, Valldeoriola F, Martí MJ.
    Neurology; 1994 Jul; 44(7 Suppl 6):S35-44. PubMed ID: 8047259
    [Abstract] [Full Text] [Related]

  • 9. Medical treatment of later-stage motor problems of Parkinson disease.
    Ahlskog JE.
    Mayo Clin Proc; 1999 Dec; 74(12):1239-54. PubMed ID: 10593354
    [Abstract] [Full Text] [Related]

  • 10. Parkinson's disease therapy: treatment of early and late disease.
    Jankovic J.
    Chin Med J (Engl); 2001 Mar; 114(3):227-34. PubMed ID: 11780303
    [Abstract] [Full Text] [Related]

  • 11. Understanding Parkinson's disease: an update on current diagnostic and treatment strategies.
    Pahwa R.
    J Am Med Dir Assoc; 2006 Sep; 7(7 Suppl 2):4-10. PubMed ID: 17948613
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Pharmacotherapy for Parkinson's disease.
    Chen JJ, Swope DM.
    Pharmacotherapy; 2007 Dec; 27(12 Pt 2):161S-173S. PubMed ID: 18041936
    [Abstract] [Full Text] [Related]

  • 14. Motor complications of Parkinson's disease.
    Martignoni E, Riboldazzi G, Calandrella D, Riva N.
    Neurol Sci; 2003 May; 24 Suppl 1():S27-9. PubMed ID: 12774208
    [Abstract] [Full Text] [Related]

  • 15. Medical management of levodopa-associated motor complications in patients with Parkinson's disease.
    Jankovic J, Stacy M.
    CNS Drugs; 2007 May; 21(8):677-92. PubMed ID: 17630819
    [Abstract] [Full Text] [Related]

  • 16. New treatments for levodopa-induced motor complications.
    Rascol O, Perez-Lloret S, Ferreira JJ.
    Mov Disord; 2015 Sep 15; 30(11):1451-60. PubMed ID: 26293004
    [Abstract] [Full Text] [Related]

  • 17. Role of the pharmacist in the effective management of wearing-off in Parkinson's disease.
    Simonson W, Hauser RA, Schapira AH.
    Ann Pharmacother; 2007 Nov 15; 41(11):1842-9. PubMed ID: 17878397
    [Abstract] [Full Text] [Related]

  • 18. Drugs for Parkinson's disease.
    Treat Guidel Med Lett; 2013 Nov 15; 11(135):101-6. PubMed ID: 24165688
    [Abstract] [Full Text] [Related]

  • 19. Advanced strategies for treatment of Parkinson's disease: the role of early treatment.
    Jann MW.
    Am J Manag Care; 2011 Oct 15; 17 Suppl 12():S315-21. PubMed ID: 22087552
    [Abstract] [Full Text] [Related]

  • 20. Parkinson's disease. Therapeutic strategies to improve patient function and quality of life.
    Danisi F.
    Geriatrics; 2002 Mar 15; 57(3):46-50; quiz 52. PubMed ID: 11899548
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 23.